Artiva Biotherapeutics, Inc. · NASDAQ:ARTV
Aslan Fred sold 27,116 Artiva Biotherapeutics, Inc. shares (Form 4)
Traded May 19, 2026 · Filed May 19, 2026
On May 19, 2026, Aslan Fred (Director, Chief Executive Officer) sold 27,116 Artiva Biotherapeutics, Inc. shares at US$9.01 for US$244K, leaving 1,535,082 shares. Filed May 19, 2026 (Form 4).
- Sold
- 27,116 shares
- Price
- US$9.01
- Value
- US$244K
- Holding after
- 1,535,082 shares
- Trading plan
- No
- Role
- Director, Chief Executive Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 19, 2026 | Common Stock | Sale | 27,116 | US$9.01 | 1,535,082 | Direct |
Source
Related
- Artiva Biotherapeutics, Inc.
- Aslan Fred
- Artiva Biotherapeutics, Inc. shareholders
- Form 4 · Aslan Fred · Oct 7, 2026
- Form 4 · Aslan Fred · Oct 6, 2026
- Form 4 · Aslan Fred · Sep 15, 2026
- Form 4 · Aslan Fred · Sep 14, 2026
- Form 4 · Aslan Fred · Sep 9, 2026
- Form 4 · Banerjee Subhashis · Oct 6, 2026
- Form 4 · Bush Jennifer · Oct 6, 2026
- Form 4 · Horan Christopher · Oct 6, 2026
- Form 4 · Miralles Gines Diego · Sep 11, 2026
- Form 4 · Horan Christopher · Sep 11, 2026